)
PMV Pharmaceuticals (PMVP) investor relations material
PMV Pharmaceuticals AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting commenced with introductions and outlined a virtual format, allowing real-time online voting until polls closed.
Agenda was displayed via webcast, and formal business was prioritized before Q&A.
Legal counsel, independent auditors, and election inspector were present, and meeting rules were provided to attendees.
Board and executive committee updates
Board size reduced from seven to six members due to Dr. Heyman not standing for re-election.
David Mack and Laurie Stelzer nominated and elected as Class III directors for terms expiring in 2029.
Shareholder proposals
Three proposals presented: election of two Class III directors, advisory approval of executive compensation, and ratification of Ernst & Young as auditor.
Board recommended approval of all proposals.
- Q1 2026 net loss was $18.0M; cash runway extends through Q2 2027 as rezatapopt advances in trials.PMVP
Q1 202612 May 2026 - Rezatapopt shows 46% ORR in ovarian cancer; NDA submission planned for Q1 2027.PMVP
TD Cowen 46th Annual Health Care Conference5 May 2026 - Key votes include director elections, executive pay, and auditor ratification.PMVP
Proxy filing22 Apr 2026 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.PMVP
Proxy filing22 Apr 2026 - Strong Phase 2 efficacy for rezatapopt in ovarian cancer; NDA planned Q1 2027.PMVP
Q4 20256 Mar 2026 - Rezatapopt delivers strong efficacy and safety in TP53 Y220C-mutant cancers, targeting 2027 approval.PMVP
Corporate presentation2 Mar 2026 - Interim Phase 2 data for rezatapopt will be released mid-2024, supporting a 2026 NDA filing.PMVP
Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 202517 Dec 2025 - Offering up to $200M in securities to fund oncology R&D, with Jefferies as sales agent.PMVP
Registration Filing16 Dec 2025 - Pivotal Phase II trial of rezatapopt targets 2026 NDA, showing strong efficacy and safety to date.PMVP
TD Cowen 45th Annual Healthcare Conference16 Dec 2025
Next PMV Pharmaceuticals earnings date
Next PMV Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage